Acta Diabetologica

, Volume 52, Issue 5, pp 845–853 | Cite as

Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study

  • Carlo B. Giorda
  • Alessandro Ozzello
  • Sandro Gentile
  • Alberto Aglialoro
  • Anna Chiambretti
  • Fabio Baccetti
  • Francesco M. Gentile
  • Giuseppe Lucisano
  • Antonio Nicolucci
  • Maria Chiara Rossi
  • HYPOS-1 Study Group of AMD
Original Article

Abstract

Objective

Hypoglycemia is common in type 1 diabetes mellitus (T1DM). We aimed to update the incidence of severe and symptomatic hypoglycemia and investigate several correlated factors.

Methods

In this multicenter, observational retrospective study, the data of 206 T1DM patients from a sample of 2,229 consecutive patients seen at 18 diabetes clinics were analyzed. Sociodemographic and clinical characteristics, severe hypoglycemia in the past 12 months, and symptomatic hypoglycemia in the past 4 weeks were recorded with a self-report questionnaire and a clinical form during a routine visit. Poisson multivariate models were applied.

Results

A minority of patients accounted for the majority of both severe and symptomatic episodes. The incidence rate (IR) of severe hypoglycemia was 0.49 (0.40–0.60) events/person-years. The incidence rate ratio (IRR) was higher in patients with previous severe hypoglycemia (3.71; 2.28–6.04), neuropathy (4.16; 2.14–8.05), long duration (>20 years, 2.96; 1.60–5.45), and on polypharmacy (1.24; 1.13–1.36), but it was lower when a complication was present. The IR of symptomatic hypoglycemia was 53.3 events/person-years, with an IRR significantly higher among women or patients with better education, or shorter duration or on pumps. The IRR was lower in patients with higher BMI or neuropathy or aged more than 50 years.

Conclusions

Fewer than 20 % of T1DM patients are free from hypoglycemia, with one in six having experienced at least one severe episode in the last year. The distribution is uneven, with a tendency of episodes to cluster in some patients. Severe and symptomatic episodes have different correlates and reflect different conditions.

Keywords

Type 1 diabetes Hypoglycemia Incidence Risks factors 

Notes

Acknowledgments

This study was organized and funded by the AMD Foundation Rome, with an unrestricted grant from Novo Nordisk.

Conflict of interest

Carlo B Giorda, Alessandro Ozzello, Sandro Gentile, Alberto Aglialoro, Anna Chiambretti, Fabio Baccetti, Francesco M. Gentile, Giuseppe Lucisano, Antonio Nicolucci and Maria Chiara Rossi declare that they have no conflict of interest.

Ethical standard

This study was approved by Institutional Interdipartimental Ethics Committee S. Luigi Hospital of Orbassano, Italy.

Human and animal rights

All procedures were carried out in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 [5].

Informed consent

Informed consent was obtained from all patients for being included in the study.

References

  1. 1.
    Cryer PE (2008) The barrier of hypoglycemia in diabetes. Diabetes 57(12):3169–3176PubMedCentralCrossRefPubMedGoogle Scholar
  2. 2.
    Briscoe VJ, Davis SN (2006) Hypoglycemia in type 1 and type 2 diabetes: physiology, pathophysiology, and management. Clin Diabetes 24(3):115–121CrossRefGoogle Scholar
  3. 3.
    The DCCT Research Group (1991) Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 90(4):450–459CrossRefGoogle Scholar
  4. 4.
    The DCCT Research Group (1997) Hypoglycemia in the diabetes control and complications trial. Diabetes 46:271–286CrossRefGoogle Scholar
  5. 5.
    Beck RW, Hirsch IB, Laffel L, Tamborlane WV, Bode BW, Buckingham B, Chase P, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Huang ES, Kollman C, Kowalski AJ, Lawrence JM, Lee J, Mauras N, O’Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer SA, Wilson DM, Wolpert H, Wysocki T, Xing D (2009) The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 32(8):1378–1383. doi: 10.2337/dc09-0108 CrossRefPubMedGoogle Scholar
  6. 6.
    Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R et al (2005) Frequency and predictors of hypoglycemia in type 1 and insulin-treated type 2 diabetes: a population based study. Diabet Med 22(6):749–755CrossRefPubMedGoogle Scholar
  7. 7.
    Heller SR, Choudhary P, Davies C, Emery C, Campbell MJ et al (2007) Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 50(6):1140–1147CrossRefGoogle Scholar
  8. 8.
    Pedersen-Bjergaard U, Pramming S, Thorsteinsson B (2003) Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. Diabetes Metab Res Rev 19(3):232–240CrossRefPubMedGoogle Scholar
  9. 9.
    Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med 150(9):604–612PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Giorda CB, Ozzello A, Gentile S, Corsi A, Iannarelli R, Baccetti F, Lucisano G, Nicolucci A, Rossi MC (2014) On behalf the HYPOS-1 study group. incidence and correlates of hypoglycemia in type 2 diabetes. The hypos-1 study. J Diabetes Metab 5:3. doi: 10.4172/2155-6156.1000344 Google Scholar
  11. 11.
    ter Braak EW, Appelman AM, van de Laak M, Stolk RP, van Haeften TW, Erkelens DW (2000) Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care 23(10):1467–1471CrossRefPubMedGoogle Scholar
  12. 12.
    The DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long term complication in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRefGoogle Scholar
  13. 13.
    Hepburn DA, MacLeod KM, Pell AC, Scougal IJ, Frier BM (1993) Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet Med 10:231–237CrossRefPubMedGoogle Scholar
  14. 14.
    Pedersen-Bjergaard U, Kristensen PL, Beck-Nielsen H, Nørgaard K, Perrild H, Christiansen JS, Jensen T, Hougaard P, Parving HH, Thorsteinsson B, Tarnow L (2014) Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial. Lancet Diabetes Endocrinol 2(7):553–561CrossRefPubMedGoogle Scholar
  15. 15.
    Amiel SA, Maran A, Powrie JK, Umpleby AM, MacDonald IA (1993) Gender differences in counterregulation to hypoglycemia. Diabetologia 36:460–464CrossRefPubMedGoogle Scholar
  16. 16.
    Davis SN, Goldstein RE, Price L, Jacobs J, Cherringon AD (1993) The effects of insulin on the counterregulatory response to equivalent hypoglycaemia in patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77:1300–1307PubMedGoogle Scholar
  17. 17.
    Diamond MP, Jones T, Caprio S, Hallarman L, Diamond MC, Addabbo M, Tamborlane WV, Sherwin RS (1993) Gender influences counterregulatory hormone responses to hypoglycemia. Metabolism 42:1568–1572CrossRefPubMedGoogle Scholar
  18. 18.
    Davis SN, Fowler S, Costa F (2000) Hypoglycemic counterregulatory responses differ between men and women with type 1 diabetes. Diabetes 49:65–72CrossRefPubMedGoogle Scholar
  19. 19.
    Sandoval DA, Ertl AC, Richardson MA, Tate DB, Davis SN (2003) Estrogen blunts neuroendocrine and metabolic responses to hypoglycemia. Diabetes 52:1749–1755CrossRefPubMedGoogle Scholar
  20. 20.
    Cherubini V, Pintaudi B, Rossi MC, Lucisano G, Pellegrini F, Chiumello G, Frongia AP, Monciotti C, Patera IP, Toni S, Zucchini S (2014) Nicolucci A; SHIP-D Study Group. Severe hypoglycemia and ketoacidosis over one year in Italian pediatric population with type 1 diabetes mellitus: a multicenter retrospective observational study. Nutr Metab Cardiovasc Dis 24(5):538–546CrossRefPubMedGoogle Scholar
  21. 21.
    McAulay V, Deary IJ, Frier BM (2001) Symptoms of hypoglycaemia in people with diabetes. Diabet Med 18(9):690–705CrossRefPubMedGoogle Scholar
  22. 22.
    Kilpatrick ES, Rigby AS, Goode K, Atkin SL (2007) Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycemia in type 1 diabetes. Diabetologia 50:2553–2561CrossRefPubMedGoogle Scholar
  23. 23.
    Sartore G, Chilelli NC, Burlina S, Di Stefano P, Piarulli F, Fedele D, Mosca A, Lapolla A (2012) The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM). Acta Diabetol 49(Suppl 1):S153–S160CrossRefPubMedGoogle Scholar
  24. 24.
    Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW (2013) Kaufman FR; ASPIRE In-Home Study Group. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 369(3):224–232CrossRefPubMedGoogle Scholar
  25. 25.
    Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S et al (2013) Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36(5):1384–1395PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2015

Authors and Affiliations

  • Carlo B. Giorda
    • 1
  • Alessandro Ozzello
    • 2
  • Sandro Gentile
    • 3
  • Alberto Aglialoro
    • 4
  • Anna Chiambretti
    • 5
  • Fabio Baccetti
    • 6
  • Francesco M. Gentile
    • 7
  • Giuseppe Lucisano
    • 8
  • Antonio Nicolucci
    • 8
  • Maria Chiara Rossi
    • 8
  • HYPOS-1 Study Group of AMD
  1. 1.Metabolism and Diabetes UnitASL TO5ChieriItaly
  2. 2.Departmental Service of Diabetology and Metabolic DiseasesASL TO3PineroloItaly
  3. 3.Department of Clinical and Experimental MedicineSecond University of NaplesNaplesItaly
  4. 4.Metabolism and Diabetes Unit Hospital St. MartinGenoaItaly
  5. 5.Metabolism and Diabetes UnitASL TO4ChivassoItaly
  6. 6.Metabolism and Diabetes UnitASL 1Massa CarraraItaly
  7. 7.Metabolism and Diabetes UnitASL di BariRutiglianoItaly
  8. 8.Laboratory of Clinical Epidemiology of Diabetes and Chronic DiseasesFondazione Mario Negri SudSanta Maria ImbaroItaly

Personalised recommendations